Please provide your email address to receive an email when new articles are posted on . LipiFlow has consistently demonstrated safety and efficacy in treating meibomian gland dysfunction. The review ...
SANTA ANA, Calif., July 24, 2021 /PRNewswire/ -- Johnson & Johnson Vision*, a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies**, today revealed new comparative ...
Please provide your email address to receive an email when new articles are posted on . Eyes that received LipiFlow treatment before cataract surgery had improved meibomian gland scores compared with ...
SANTA ANA, Calif., Feb. 5, 2018 /PRNewswire/ -- Johnson & Johnson Vision announced today the simultaneous publication of two studies in Clinical Ophthalmology demonstrating the patient and clinical ...